mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.006 |
mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
0.089 |
0.007 |
mRNA |
MK-2206 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.007 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.008 |
mRNA |
darinaparsin |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.01 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.01 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.01 |
mRNA |
NSC632839 |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.01 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.01 |
mRNA |
BRD6340 |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.01 |